Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review
- PMID: 32816059
- PMCID: PMC7439803
- DOI: 10.1007/s00066-020-01675-z
Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review
Abstract
Background: The COVID-19 pandemic outbreak has set the emergency services in developing countries on major alert, as the installed response capacities are easily overwhelmed by the constantly increasing high demand. The deficit of intensive care unit beds and ventilators in countries like Peru is forcing practitioners to seek preventive or early interventional strategies to prevent saturating these chronically neglected facilities.
Case presentation: A 64-year-old patient is reported after presenting with COVID-19 pneumonia and rapidly progressing to deteriorated ventilatory function. Compassionate treatment with a single 1‑Gy dose to the bilateral whole-lung volume was administered, with gradual daily improvement of ventilatory function and decrease in serum inflammatory markers and oxygen support needs, including intubation. No treatment-related toxicity developed. Procedures of transport, disinfection, and treatment planning and delivery are described.
Conclusion: Whole-lung low-dose radiotherapy seems to be a promising approach for avoiding or delaying invasive respiratory support. Delivered low doses are far from meeting toxicity ranges. On-going prospective trials will elucidate the effectiveness of this approach.
Keywords: COVID-19; Cytokine storm; Intensive care; Low-dose radiotherapy; Viral pneumonia.
Conflict of interest statement
R. Del Castillo, D. Martinez, G.J. Sarria, L. Pinillos, B. Garcia, L. Castillo, and A. Carhuactocto declare that they have no competing interests. F.A. Giordano reports personal fees from Implacit GmbH, non-financial support from Oncare GmbH, grants and personal fees from NOXXON Pharma AG, grants and personal fees from CARL ZEISS MEDITEC AG, personal fees from Bristol-Myers Squibb, personal fees from Roche Pharma AG, personal fees from MSD Sharp and Dohme GmbH, personal fees from AstraZeneca GmbH, outside the submitted work. In addition, F.A. Giordano has a patent (US 62/435405) pending, not related to the submitted work. G.R. Sarria reports grants and personal fees from Carl Zeiss Meditec AG, not related to the submitted work.
Figures



Similar articles
-
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.Infez Med. 2020 Jun 1;28(suppl 1):118-121. Infez Med. 2020. PMID: 32532948
-
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.Cardiol Young. 2021 Mar;31(3):507-510. doi: 10.1017/S1047951120004291. Epub 2020 Nov 13. Cardiol Young. 2021. PMID: 33183365 Free PMC article.
-
Efficacy of canakinumab in mild or severe COVID-19 pneumonia.Immun Inflamm Dis. 2021 Jun;9(2):399-405. doi: 10.1002/iid3.400. Epub 2021 Jan 19. Immun Inflamm Dis. 2021. PMID: 33465283 Free PMC article.
-
COVID-19 and Its Implications for Thrombosis and Anticoagulation.Semin Respir Crit Care Med. 2021 Apr;42(2):316-326. doi: 10.1055/s-0041-1722992. Epub 2021 Feb 6. Semin Respir Crit Care Med. 2021. PMID: 33548929 Review.
-
Possible treatment and strategies for COVID-19: review and assessment.Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12593-12608. doi: 10.26355/eurrev_202012_24057. Eur Rev Med Pharmacol Sci. 2020. PMID: 33336780 Review.
Cited by
-
COVID-19 and tuberculosis coinfection: An overview of case reports/case series and meta-analysis of prevalence studies.Heliyon. 2023 Feb;9(2):e13637. doi: 10.1016/j.heliyon.2023.e13637. Epub 2023 Feb 10. Heliyon. 2023. PMID: 36789387 Free PMC article. Review.
-
Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia.Antioxidants (Basel). 2022 Jun 16;11(6):1184. doi: 10.3390/antiox11061184. Antioxidants (Basel). 2022. PMID: 35740079 Free PMC article.
-
Low-Dose Whole Lung Irradiation for Treatment of COVID-19 Pneumonia: A Systematic Review and Meta-Analysis.Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):946-959. doi: 10.1016/j.ijrobp.2022.04.043. Epub 2022 May 7. Int J Radiat Oncol Biol Phys. 2022. PMID: 35537577 Free PMC article.
-
Radiotherapy and COVID-19-everything under control or just the start of a long story?Strahlenther Onkol. 2020 Dec;196(12):1065-1067. doi: 10.1007/s00066-020-01704-x. Strahlenther Onkol. 2020. PMID: 33231738 Free PMC article. No abstract available.
-
Low-dose radiation therapy for COVID-19 pneumonia: a pilot study.Br J Radiol. 2021 Oct 1;94(1126):20210187. doi: 10.1259/bjr.20210187. Br J Radiol. 2021. PMID: 34545760 Free PMC article.
References
-
- Available from: https://rpp.pe/politica/gobierno/coronavius-comando-covid-quedan-185-cam.... Accessed 29 May 2020
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical